134 related articles for article (PubMed ID: 37335208)
1. Renoprotective Effect of Isoorientin in Diabetic Nephropathy via Activating Autophagy and Inhibiting the PI3K-AKT-TSC2-mTOR Pathway.
Kong Z; Xiao M; Wang B; Zhang W; Che K; Lv W; Wang Y; Huang Y; Zhao H; Zhao Y; Qi M; Chi J; Wang Y
Am J Chin Med; 2023; 51(5):1269-1291. PubMed ID: 37335208
[TBL] [Abstract][Full Text] [Related]
2. Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K/AKT/mTOR pathways to protect against diabetic nephropathy in mice.
Yang F; Qu Q; Zhao C; Liu X; Yang P; Li Z; Han L; Shi X
Biomed Pharmacother; 2020 Sep; 129():110479. PubMed ID: 32768963
[TBL] [Abstract][Full Text] [Related]
3. [Down-regulation of PHLPP1 expression ameliorates high glucose-induced autophagy inhibition and apoptosis promotion of podocytes by activating PI3K/AKT/mTOR pathway].
Cai G; Zhang J; Wang R
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jan; 37(1):8-15. PubMed ID: 33441223
[TBL] [Abstract][Full Text] [Related]
4.
Chen Y; Zheng YF; Lin XH; Zhang JP; Lin F; Shi H
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165163
[No Abstract] [Full Text] [Related]
5. Spironolactone promotes autophagy via inhibiting PI3K/AKT/mTOR signalling pathway and reduce adhesive capacity damage in podocytes under mechanical stress.
Li D; Lu Z; Xu Z; Ji J; Zheng Z; Lin S; Yan T
Biosci Rep; 2016 Aug; 36(4):. PubMed ID: 27129295
[TBL] [Abstract][Full Text] [Related]
6. Butyrate ameliorates skeletal muscle atrophy in diabetic nephropathy by enhancing gut barrier function and FFA2-mediated PI3K/Akt/mTOR signals.
Tang G; Du Y; Guan H; Jia J; Zhu N; Shi Y; Rong S; Yuan W
Br J Pharmacol; 2022 Jan; 179(1):159-178. PubMed ID: 34638162
[TBL] [Abstract][Full Text] [Related]
7. Curcumin alleviates diabetic nephropathy via inhibiting podocyte mesenchymal transdifferentiation and inducing autophagy in rats and MPC5 cells.
Tu Q; Li Y; Jin J; Jiang X; Ren Y; He Q
Pharm Biol; 2019 Dec; 57(1):778-786. PubMed ID: 31741405
[No Abstract] [Full Text] [Related]
8. Rutin alleviates EndMT by restoring autophagy through inhibiting HDAC1 via PI3K/AKT/mTOR pathway in diabetic kidney disease.
Dong R; Zhang X; Liu Y; Zhao T; Sun Z; Liu P; Xiang Q; Xiong J; Du X; Yang X; Gui D; Xu Y
Phytomedicine; 2023 Apr; 112():154700. PubMed ID: 36774842
[TBL] [Abstract][Full Text] [Related]
9. LncRNA Hoxb3os protects podocytes from high glucose-induced cell injury through autophagy dependent on the Akt-mTOR signaling pathway.
Jin J; Gong J; Zhao L; Li Y; He Q
Acta Biochim Pol; 2021 Oct; 68(4):619-625. PubMed ID: 34648253
[TBL] [Abstract][Full Text] [Related]
10. Jiedu Tongluo Baoshen formula enhances podocyte autophagy and reduces proteinuria in diabetic kidney disease by inhibiting PI3K/Akt/mTOR signaling pathway.
Jin D; Liu F; Yu M; Zhao Y; Yan G; Xue J; Sun Y; Zhao D; Li X; Qi W; Wang X
J Ethnopharmacol; 2022 Jul; 293():115246. PubMed ID: 35398500
[TBL] [Abstract][Full Text] [Related]
11. p66Shc regulates podocyte autophagy in high glucose environment through the Notch-PTEN-PI3K/Akt/mTOR pathway.
Zheng D; Tao M; Liang X; Li Y; Jin J; He Q
Histol Histopathol; 2020 Apr; 35(4):405-415. PubMed ID: 31650524
[TBL] [Abstract][Full Text] [Related]
12. KCa3.1 mediates dysfunction of tubular autophagy in diabetic kidneys via PI3k/Akt/mTOR signaling pathways.
Huang C; Lin MZ; Cheng D; Braet F; Pollock CA; Chen XM
Sci Rep; 2016 Mar; 6():23884. PubMed ID: 27029904
[TBL] [Abstract][Full Text] [Related]
13. Qizhi Jiangtang capsule activates podocyte autophagy in diabetic kidney disease by inhibiting phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin pathways.
Zhaoan G; Lina S; Yingying L; Ruifeng LI; Chong L; Ke D; Jing S; Jun S
J Tradit Chin Med; 2023 Aug; 43(4):667-675. PubMed ID: 37454251
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SOX2OT alleviates mesangial cell proliferation and fibrosis in diabetic nephropathy via Akt/mTOR-mediated autophagy.
Chen K; Yu B; Liao J
Mol Med; 2021 Jul; 27(1):71. PubMed ID: 34238205
[TBL] [Abstract][Full Text] [Related]
15. Paeoniflorin binds to VEGFR2 to restore autophagy and inhibit apoptosis for podocyte protection in diabetic kidney disease through PI3K-AKT signaling pathway.
Wang X; Jiang L; Liu XQ; Huang YB; Wang AL; Zeng HX; Gao L; Zhu QJ; Xia LL; Wu YG
Phytomedicine; 2022 Nov; 106():154400. PubMed ID: 36049428
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux.
Jin J; Gong J; Zhao L; Zhang H; He Q; Jiang X
J Diabetes; 2019 Oct; 11(10):826-836. PubMed ID: 30864227
[TBL] [Abstract][Full Text] [Related]
17. Irisin ameliorates diabetic kidney disease by restoring autophagy in podocytes.
Lai W; Luo D; Li Y; Li Y; Wang Q; Hu Z; Ye Z; Peng H
FASEB J; 2023 Oct; 37(10):e23175. PubMed ID: 37742293
[TBL] [Abstract][Full Text] [Related]
18. Notoginsenoside R1 attenuates glucose-induced podocyte injury via the inhibition of apoptosis and the activation of autophagy through the PI3K/Akt/mTOR signaling pathway.
Huang G; Zou B; Lv J; Li T; Huai G; Xiang S; Lu S; Luo H; Zhang Y; Jin Y; Wang Y
Int J Mol Med; 2017 Mar; 39(3):559-568. PubMed ID: 28112381
[TBL] [Abstract][Full Text] [Related]
19. SPAG5-AS1 inhibited autophagy and aggravated apoptosis of podocytes via SPAG5/AKT/mTOR pathway.
Xu J; Deng Y; Wang Y; Sun X; Chen S; Fu G
Cell Prolif; 2020 Feb; 53(2):e12738. PubMed ID: 31957155
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end-products suppress autophagic flux in podocytes by activating mammalian target of rapamycin and inhibiting nuclear translocation of transcription factor EB.
Zhao X; Chen Y; Tan X; Zhang L; Zhang H; Li Z; Liu S; Li R; Lin T; Liao R; Zhang Q; Dong W; Shi W; Liang X
J Pathol; 2018 Jun; 245(2):235-248. PubMed ID: 29570219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
